Ligand validation:5S83

LU8: 4-methyl-3-[4-(1-methylpiperidin-4-yl)phenyl]-5-(3,4,5-trimethoxyphenyl)pyridine

LU8 is a Ligand Of Interest in 5S83 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5S83_LU8_A_501	89%	41%	0.085	0.964	0.9	1.38	-	6	0	0	100%	0.56
5S83_LU8_B_501	87%	38%	0.082	0.955	0.98	1.45	1	5	0	0	100%	1
5S83_LU8_A_509	83%	28%	0.087	0.944	1.11	1.76	2	14	0	0	100%	1
5S83_LU8_A_508	58%	28%	0.14	0.917	1.12	1.75	2	8	0	0	100%	1
6SRH_LU8_B_502	96%	37%	0.068	0.975	0.62	1.8	-	8	0	0	100%	1
5S7M_LU8_B_501	92%	19%	0.065	0.956	1.16	2.24	2	10	0	0	100%	1
5S7X_LU8_B_501	91%	29%	0.076	0.962	1.16	1.67	3	9	0	0	100%	1
5S7I_LU8_B_501	89%	31%	0.075	0.955	1.1	1.64	3	8	0	0	100%	1
5S7K_LU8_A_507	89%	33%	0.072	0.951	1.17	1.46	4	6	0	0	100%	1
5S78_LU8_B_501	89%	26%	0.076	0.955	1.19	1.78	3	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.